{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:38:52Z","timestamp":1789911532166,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009567","name":"Conseil R\u00e9gional de Franche-Comt\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009567","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bioorg.2019.103205","type":"journal-article","created":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T11:29:21Z","timestamp":1565954961000},"page":"103205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Multi-target 1,4-dihydropyridines showing calcium channel blockade and antioxidant capacity for Alzheimer\u2019s disease therapy"],"prefix":"10.1016","volume":"91","author":[{"given":"Rim","family":"Malek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Maj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Wnorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"J\u00f3\u017awiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Iriepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Moraleda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakher","family":"Chabchoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Marco-Contelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lhassane","family":"Ismaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.103205_b0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2019.103205_b0010","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2019.103205_b0015","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1021\/jm400970m","article-title":"Oxidative stress in Alzheimer\u2019s disease: are we connecting the dots?","volume":"57","author":"Rosini","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103205_b0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/JAD-2008-15208","article-title":"Drug development based on the metals hypothesis of Alzheimer\u2019s disease","volume":"15","author":"Bush","year":"2008","journal-title":"J. Alzheimers Dis. JAD."},{"key":"10.1016\/j.bioorg.2019.103205_b0025","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2174\/1871527313666141023141545","article-title":"Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer\u2019s disease and type 2 diabetes mellitus","volume":"13","author":"Mushtaq","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets."},{"key":"10.1016\/j.bioorg.2019.103205_b0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000353801","article-title":"Memantine in patients with moderate to severe Alzheimer\u2019s disease: meta-analyses using realistic definitions of response","volume":"37","author":"Wilkinson","year":"2014","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.bioorg.2019.103205_b0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1021\/acschemneuro.8b00069","article-title":"Alzheimer\u2019s disease, the \u201cone-molecule, one-target\u201d paradigm, and the multitarget directed ligand approach","volume":"9","author":"Oset-Gasque","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103205_b0040","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1021\/jm800210c","article-title":"Multi-target-directed ligands to combat neurodegenerative diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103205_b0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/med.20248","article-title":"Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer\u2019s disease","volume":"33","author":"Le\u00f3n","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2019.103205_b0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4155\/fmc.14.148","article-title":"Donepezil\u2013ferulic acid hybrids as anti-Alzheimer drugs","volume":"7","author":"Benchekroun","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103205_b0055","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1021\/acs.jmedchem.6b01178","article-title":"The antioxidant additive approach for Alzheimer\u2019s disease therapy: new ferulic (lipoic) acid plus melatonin modified tacrines as cholinesterases inhibitors, direct antioxidants, and nuclear factor (erythroid-derived 2)-like 2 activators","volume":"59","author":"Benchekroun","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103205_b0060","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.2174\/1568026618666180112155424","article-title":"Multicomponent reactions for multitargeted compounds for Alzheimer\u2019s disease","volume":"17","author":"Ismaili","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103205_b0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejps.2018.07.031","article-title":"Preparation of novel tissue acidosis-responsive chitosan drug nanoparticles: Characterization and in vitro release properties of Ca2+ channel blocker nimodipine drug molecules","volume":"123","author":"Janov\u00e1k","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2019.103205_b0070","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4155\/fmc-2017-0014","article-title":"Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration","author":"Ramos","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103205_b0075","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pharep.2015.07.006","article-title":"Therapeutic strategies for Alzheimer\u2019s disease in clinical trials","volume":"68","author":"Gody\u0144","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bioorg.2019.103205_b0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1461145711000149","article-title":"Increased NF-\u03baB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer\u2019s disease","volume":"15","author":"Chen","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bioorg.2019.103205_b0085","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF03033284","article-title":"Tau in neurodegenerative diseases: Tau phosphorylation and assembly","volume":"6","author":"Avila","year":"2004","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bioorg.2019.103205_b0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2013.11.012","article-title":"Calcium channelopathies and Alzheimer\u2019s disease: insight into therapeutic success and failures","volume":"739","author":"Chakroborty","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2019.103205_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jpi.12189","article-title":"Melatonin feedback on clock genes: a theory involving the proteasome","volume":"58","author":"Vriend","year":"2015","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.bioorg.2019.103205_b0100","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/jpi.12267","article-title":"Melatonin: an ancient molecule that makes oxygen metabolically tolerable","volume":"59","author":"Manchester","year":"2015","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.bioorg.2019.103205_b0105","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.lfs.2006.01.030","article-title":"Melatonin directly scavenges free radicals generated in red blood cells and a cell-free system: chemiluminescence measurements and theoretical calculations","volume":"79","author":"Zavodnik","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2019.103205_b0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jpi.12162","article-title":"Melatonin: a well-documented antioxidant with conditional pro-oxidant actions","volume":"57","author":"Zhang","year":"2014","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.bioorg.2019.103205_b0115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mce.2014.12.013","article-title":"The Keap1-Nrf2-antioxidant response element pathway: a review of its regulation by melatonin and the proteasome","volume":"401","author":"Vriend","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bioorg.2019.103205_b0120","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103205_b0125","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1039\/c39870000653","article-title":"A novel two-stage route to the 2a,5a-diazacyclopenta[jk]fluorene ring system","author":"Jackson","year":"1987","journal-title":"J. Chem. Soc. Chem. Commun."},{"key":"10.1016\/j.bioorg.2019.103205_b0130","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ejmech.2018.06.044","article-title":"Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer\u2019s disease","volume":"155","author":"Chioua","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103205_b0135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1021\/jf0305231","article-title":"Extending applicability of the oxygen radical absorbance capacity (ORAC\u2212Fluorescein) assay","volume":"52","author":"D\u00e1valos","year":"2004","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2019.103205_b0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819308417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819308417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:58:02Z","timestamp":1758614282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819308417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":28,"alternative-id":["S0045206819308417"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103205","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-target 1,4-dihydropyridines showing calcium channel blockade and antioxidant capacity for Alzheimer\u2019s disease therapy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103205"}}